Structures by: Rajbanshi A.
Total: 34
AR-ZZ4 pentyl 4-pyridyl cavitand, 1,4-I2-F4-benzene
(C72H76N4O8)(C6F4I2)2(C2H3N)2
CrystEngComm (2012) 14, 20 6366
a=12.3175(5)Å b=13.2596(6)Å c=25.4769(11)Å
α=88.893(2)° β=88.152(2)° γ=79.980(2)°
C159H160.5F16I4N9.5O16
C159H160.5F16I4N9.5O16
CrystEngComm (2012) 14, 20 6366
a=18.758(3)Å b=19.828(3)Å c=22.558(3)Å
α=100.106(10)° β=98.682(10)° γ=110.342(9)°
P50 2-aminopyrazine, (4-NO2-PhCOOH)2
(C4H5N3)(C7H5NO4)2
CrystEngComm (2012) 14, 18 5845
a=13.8994(7)Å b=5.4845(3)Å c=13.1317(6)Å
α=90.00° β=101.948(2)° γ=90.00°
P55 2-aminopyrazine, 3-NO2-PhCOOH
(C4H5N3)(C7H5NO4)2
CrystEngComm (2012) 14, 18 5845
a=5.9930(10)Å b=12.1894(18)Å c=12.995(2)Å
α=90.00° β=98.803(8)° γ=90.00°
P54 2-aminopyrazine, 3,5-(NO2)2-PhCOOH
(C4H5N3)(C7H4N2O6)
CrystEngComm (2012) 14, 18 5845
a=7.6755(11)Å b=8.8822(11)Å c=9.6107(15)Å
α=84.645(10)° β=82.063(11)° γ=74.877(10)°
D3 2-aminopyrazine, HOOC-(CH2)2-COOH
(C4H5N3)2(C4H6O4)
CrystEngComm (2012) 14, 18 5845
a=5.3982(9)Å b=19.505(3)Å c=6.9524(12)Å
α=90.00° β=104.487(10)° γ=90.00°
D9 2-aminopyrazine, HOOC-(CH2)5-COOH
(C4H5N3)(C7H12O4)
CrystEngComm (2012) 14, 18 5845
a=5.0231(5)Å b=34.308(3)Å c=7.4377(8)Å
α=90.00° β=102.850(5)° γ=90.00°
D4 2-aminopyrazine, HOOC-(CH2)8-COOH
(C4H5N3)(C10H18O4)
CrystEngComm (2012) 14, 18 5845
a=5.7935(6)Å b=7.5090(8)Å c=8.7271(8)Å
α=92.984(4)° β=91.952(5)° γ=98.570(5)°
P13 2,6-Br2-3-NH2-pyrazine, 2,5-(HO)2-PhCOOH
(C4H3N3Br2)(C7H6O4)
CrystEngComm (2012) 14, 18 5845
a=6.8754(7)Å b=7.1197(7)Å c=13.8665(14)Å
α=87.951(3)° β=86.435(3)° γ=72.915(4)°
AR-cc-2c-10 2,6-dibromo-3-aminopyrazine, F5-PhCOOH
(C4H3N3Br2)(C7HF5O2)
CrystEngComm (2012) 14, 18 5845
a=15.5511(6)Å b=5.8057(2)Å c=16.0859(6)Å
α=90.00° β=111.0750(10)° γ=90.00°
P9 2-amino-3,5-dibromopyrazine, 3,5-(NO2)2-PhCOOH
(C4H3N3Br2)(C7H4N2O6)
CrystEngComm (2012) 14, 18 5845
a=7.3153(3)Å b=10.4607(4)Å c=10.8371(4)Å
α=65.094(2)° β=83.688(2)° γ=89.742(2)°
ARcc-2c-7 2-amino-3,5-dibromopyrazine, 2,6-difluorobenzoic acid
(C4H3N3Br2)(C7H4O2F2)
CrystEngComm (2012) 14, 18 5845
a=5.6663(5)Å b=13.2299(11)Å c=17.3426(14)Å
α=90.00° β=93.911(4)° γ=90.00°
D8 2-aminopyrazine, HOOC-(CH2)3-COOH
(C4H5N3)(C5H8O4)
CrystEngComm (2012) 14, 18 5845
a=5.2487(3)Å b=29.2633(18)Å c=7.2357(5)Å
α=90.00° β=104.958(3)° γ=90.00°
D5 2-aminopyrazine, HOOC-(CH2)6-COOH
(C4H5N3)(C8H14O4)
CrystEngComm (2012) 14, 18 5845
a=7.7749(5)Å b=9.8014(7)Å c=9.2097(6)Å
α=90.00° β=101.560(3)° γ=90.00°
AI5 cavitand
(C70H74N4O10BR2)(C3H6O)2(C6H14)0.5
Chem.Commun. (2011) 47, 11411
a=13.3457(7)Å b=19.5826(9)Å c=14.0550(8)Å
α=90.00° β=99.793(2)° γ=90.00°
AR-AI-11 pentyl (6-acetylamino-3-pyridyl)ethynyl cavitand
(C88H88N8O12)(C7H8)0.7(C2H5O1)3.4(C1H3O1)0.9(O1)0.5
Chem.Commun. (2011) 47, 11411
a=14.7722(7)Å b=15.9370(8)Å c=22.1716(11)Å
α=109.733(3)° β=96.094(3)° γ=93.890(3)°
AR-1g-15 2-aminopyridine, HOOC-(CH2)8-COOH
(C5H6N2)2(C10H18O4)
CrystEngComm (2010) 12, 12 4231
a=8.2382(6)Å b=7.3603(5)Å c=17.7902(11)Å
α=90.00° β=102.979(3)° γ=90.00°
AR-1g-3 2-aminopyridine, 4-chlorobenzoic acid
(C5H6N2)(C7H5O2Cl)
CrystEngComm (2010) 12, 12 4231
a=6.6153(14)Å b=7.9832(17)Å c=11.143(3)Å
α=90.00° β=99.763(5)° γ=90.00°
AR-cc-1a-1 2-amino-5-bromopyridine, 4-NC-PhCOOH
(C5H5N2Br)(C8H5NO2)
CrystEngComm (2010) 12, 12 4231
a=12.3903(8)Å b=5.6871(3)Å c=18.0290(11)Å
α=90.00° β=90.00° γ=90.00°
ARcc-1a-aa5 2-amino-5-bromopyridine, 4-nitrobenzoic acid
(C5H5N2Br)(C7H5NO4)
CrystEngComm (2010) 12, 12 4231
a=7.9727(5)Å b=6.2956(4)Å c=24.6286(15)Å
α=90.00° β=90.580(4)° γ=90.00°
ARcc-1c-aa6 N-(5-bromo-2-pyridyl)propionamide, 3,4-Cl2-PhCOOH
(C8H9N2OBR)(C7H4O2Cl2)
CrystEngComm (2010) 12, 12 4231
a=3.9019(2)Å b=12.5454(8)Å c=16.9260(10)Å
α=73.128(3)° β=86.428(3)° γ=85.881(3)°
AR-1c-aa13 [N-(5-bromo-2-pyridyl)propionamide]2, fumaric acid
(C8H9N2OBr)2(C4H4O4)
CrystEngComm (2010) 12, 12 4231
a=4.8333(3)Å b=9.5923(5)Å c=23.7901(12)Å
α=90.00° β=90.961(2)° γ=90.00°
AR-1c-aa-14 N-(5-bromo-2-pyridyl)-propionamide, succinic acid
(C8H9N2OBr)2(C4H6O4)
CrystEngComm (2010) 12, 12 4231
a=13.8624(15)Å b=13.9754(16)Å c=24.726(3)Å
α=95.707(8)° β=90.355(7)° γ=101.437(7)°
AR-BI-C4 N-(5-bromo-2-pyridyl)propionamide, HOOC-(CH2)8-COOH
(C8H9N2OBr)2(C10H18O4)
CrystEngComm (2010) 12, 12 4231
a=5.1849(4)Å b=11.4665(8)Å c=12.4870(9)Å
α=71.293(2)° β=81.204(2)° γ=88.593(2)°
AR-1i-13 2-amino-3,5-dibromopyridine, fumaric acid
(C5H4N2Br2)2(C4H4O4)
CrystEngComm (2010) 12, 12 4231
a=14.0298(10)Å b=3.8527(3)Å c=17.5918(13)Å
α=90.00° β=102.337(3)° γ=90.00°
(N-5-bromo-2-pyridyl)-acetamide)2, fumaric acid
(C7H7N2OBr)2(C4H6O4)
CrystEngComm (2010) 12, 12 4231
a=4.9878(3)Å b=9.9931(7)Å c=11.4625(8)Å
α=113.250(5)° β=92.103(5)° γ=93.352(5)°
L1-2H2O
C24H34N10O5
Crystal Growth & Design (2011) 11, 7 2702
a=8.4436(5)Å b=12.2377(8)Å c=13.6622(8)Å
α=95.3550(10)° β=100.0760(10)° γ=105.0520(10)°
1
C24H34N10NaO7S0.5
Crystal Growth & Design (2011) 11, 7 2702
a=12.1207(6)Å b=18.8019(9)Å c=13.2832(7)Å
α=90.00° β=91.6320(10)° γ=90.00°
2
C24H32KN10O6S0.5
Crystal Growth & Design (2011) 11, 7 2702
a=11.9118(7)Å b=18.5604(11)Å c=12.8360(7)Å
α=90.00° β=91.6400(10)° γ=90.00°
C81H162N11O19P3
C81H162N11O19P3
Crystal Growth & Design (2013) 13, 5 2233
a=13.9538(15)Å b=17.1425(18)Å c=22.245(2)Å
α=99.483(2)° β=90.133(3)° γ=113.454(2)°
C77H154N11O19P3
C77H154N11O19P3
Crystal Growth & Design (2013) 13, 5 2233
a=14.0158(12)Å b=17.1001(15)Å c=22.014(2)Å
α=79.749(2)° β=89.457(2)° γ=66.057(2)°
C45H91N6O10P2
C45H91N6O10P2
Crystal Growth & Design (2013) 13, 5 2233
a=12.5433(14)Å b=15.2724(16)Å c=16.7800(18)Å
α=83.775(2)° β=79.502(2)° γ=68.296(2)°
(N-5-bromo-2-pyridyl)-propionamide)2, octanedioic acid
(C8H9N2OBr)2(C8H14O4)
CrystEngComm (2010) 12, 12 4231
a=5.3172(2)Å b=8.6548(3)Å c=14.9927(6)Å
α=101.970(2)° β=93.037(2)° γ=100.816(2)°
AR-1i-9 2-amino-3,5-dibromopyridine, 3,5-dinitrobenzoic acid
(C5H4Br2N2)(C7H4N2O6)
CrystEngComm (2010) 12, 12 4231
a=7.3849(5)Å b=31.340(2)Å c=13.3082(9)Å
α=90.00° β=90.344(3)° γ=90.00°